Inify laboratories gain medical lab accreditation
Inify Laboratories, a provider of specialist cancer diagnostics in pathology, has been granted accreditation as a medical laboratory in line with the ISO 15189 standard.
Fredrik Palm, CEO of Inify Laboratories, commented: “To be accredited within five months of launching a completely unique laboratory service for cancer diagnostics must be some kind of record. It is yet another confirmation of the ability, quality awareness, and breadth of knowledge that Inify possesses.”
Johanna Karling, Chief Quality Officer at Inify Laboratories, stated: “For Inify, this is proof that our business lives up to the high standards we set for ourselves. Going through the accreditation process has involved the entire organisation, where the whole team has contributed with expertise and commitment to get every piece in place. We intend to proudly maintain and further develop what this accreditation means for us, namely a culture of quality thinking and continuous improvement, which permeates all parts of the business.”
Accreditation is an international system with common legislation within the EU and can be awarded to organisations that conduct sampling and testing, such as medical laboratories. In Sweden, Swedac is the accrediting body that carries out an independent review to assess the competence of organisations.
Inify has passed this assessment, which scrutinised the company’s procedures and processes for quality management, staff competencies, and documentation to ensure that it meets the requisite standards and guidelines. Following this, Swedac has issued an accreditation certificate to Inify Laboratories.
Public sector healthcare institutions often have a stipulation to use services from accredited medical laboratories.
Palm added: “This is one of the main keys to the market, enabling us to accelerate our journey towards offering high-quality cancer diagnostics with short, predictable response times to as many patients as possible.”